je.st
news
Tag: world conference
Drive World Conference & Expo
2019-07-08 21:28:37| Canadian Plastics Headlines
Cars are getting smarter. But the shift to Level 5 autonomy will take time, testing, and, most of all, the technical chops to perfect the connected car at the component level. That means sensors, 5G, systems on chip, and other… The post Drive World Conference & Expo appeared first on Canadian Plastics.
Tags: world
drive
conference
expo
Plastic Free World Conference & Expo
2018-12-11 22:04:51| Canadian Plastics Headlines
Plastic Free World Conference & Expo is a two-day conference and exhibition for businesses looking to reduce their plastic consumption, find and source highly sustainable alternative bio-based materials, and create a more circular economy throughout their supply chain. The event… The post Plastic Free World Conference & Expo appeared first on Canadian Plastics.
Tags: free
world
conference
plastic
33rd Annual World Petrochemical Conference
2018-02-12 19:57:19| Canadian Plastics Headlines
Global chemical, refining, and oil industry leaders and experts — as well as leaders from the technology and construction sectors — will be among those to address WPC 2018 by IHS Markit, March 1923, 2018, at the Hilton Americas Hotel… The post 33rd Annual World Petrochemical Conference appeared first on Canadian Plastics.
Tags: world
annual
conference
annual conference
Nutriad sponsor 6th Leman China Swine Conference & World Swine Industry Expo
2017-11-10 01:00:00| ThePigSite - Industry News
The 6th Leman China Swine Conference & World Swine Industry Expo was held in Nanjing City, China on November 2-4. As an industry leader for feed additives, NUTRIAD was proud to be one of the sponsors of the renowned event.
Tags: world
china
industry
conference
Updated KEYTRUDA (pembrolizumab) Data in Small Cell Lung Cancer and Mesothelioma Presented at 17th World Conference on Lung Cancer
2016-12-06 14:20:00| Merck.com - Product News
Dateline City: KENILWORTH, N.J. Findings in Small Cell Lung Cancer and Malignant Pleural Mesothelioma Show Overall Response Rates of 33.3 Percent and 20.0 Percent, Respectively, in KEYNOTE-028 Long-Term Data Demonstrate Durable Responses in Difficult-to-Treat Cancers KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that updated findings from the phase 1b KEYNOTE-028 study investigating the use of KEYTRUDA (pembrolizumab), the companys anti-PD-1 therapy, in previously treated patients with advanced small cell lung cancer (SCLC) and malignant pleural mesothelioma, showed clinical activity and durable responses in some patients. Language: English Contact: Media:Pamela Eisele, 267-305-3558orCourtney Ronaldo, 908-236-1108orInvestorsTeri Loxam, 908-740-1986orAmy Klug, 908-740-1898 Ticker Slug: Ticker: MRK Exchange: NYSE @Merck read more